These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 31951754)

  • 1. Use of imaging to assess the activity of hepatic transporters.
    Hernández Lozano I; Langer O
    Expert Opin Drug Metab Toxicol; 2020 Feb; 16(2):149-164. PubMed ID: 31951754
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluorescence-based methods for studying activity and drug-drug interactions of hepatic solute carrier and ATP binding cassette proteins involved in ADME-Tox.
    Özvegy-Laczka C; Ungvári O; Bakos É
    Biochem Pharmacol; 2023 Mar; 209():115448. PubMed ID: 36758706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET Tracers To Study Clinically Relevant Hepatic Transporters.
    Testa A; Zanda M; Elmore CS; Sharma P
    Mol Pharm; 2015 Jul; 12(7):2203-16. PubMed ID: 26034841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo.
    Mairinger S; Erker T; Muller M; Langer O
    Curr Drug Metab; 2011 Oct; 12(8):774-92. PubMed ID: 21434859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview: Role of Drug Transporters in Drug Disposition and Its Clinical Significance.
    Liu X
    Adv Exp Med Biol; 2019; 1141():1-12. PubMed ID: 31571163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental regulation of kidney and liver solute carrier and ATP-binding cassette drug transporters and drug metabolizing enzymes: the role of remote organ communication.
    Momper JD; Nigam SK
    Expert Opin Drug Metab Toxicol; 2018 Jun; 14(6):561-570. PubMed ID: 29746174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sandwich-Cultured Hepatocytes for Mechanistic Understanding of Hepatic Disposition of Parent Drugs and Metabolites by Transporter-Enzyme Interplay.
    Matsunaga N; Fukuchi Y; Imawaka H; Tamai I
    Drug Metab Dispos; 2018 May; 46(5):680-691. PubMed ID: 29352067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Contribution of Six Major Transporters to the Hepatic Uptake of Drugs: "SLC-Phenotyping" Using Primary Human Hepatocytes.
    Bi YA; Costales C; Mathialagan S; West M; Eatemadpour S; Lazzaro S; Tylaska L; Scialis R; Zhang H; Umland J; Kimoto E; Tess DA; Feng B; Tremaine LM; Varma MVS; Rodrigues AD
    J Pharmacol Exp Ther; 2019 Jul; 370(1):72-83. PubMed ID: 30975793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of PET Imaging to Evaluate Transporter-Mediated Drug-Drug Interactions.
    Langer O
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S143-56. PubMed ID: 27385172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Structure and Mechanism of Drug Transporters.
    Roberts AG
    Methods Mol Biol; 2021; 2342():193-234. PubMed ID: 34272696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug transport proteins in the liver.
    Faber KN; Müller M; Jansen PL
    Adv Drug Deliv Rev; 2003 Jan; 55(1):107-24. PubMed ID: 12535576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of gadoxetate DCE-MRI as a biomarker of hepatobiliary transporter inhibition.
    Ulloa JL; Stahl S; Yates J; Woodhouse N; Kenna JG; Jones HB; Waterton JC; Hockings PD
    NMR Biomed; 2013 Oct; 26(10):1258-70. PubMed ID: 23564602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Kinases C-Mediated Regulations of Drug Transporter Activity, Localization and Expression.
    Mayati A; Moreau A; Le Vée M; Stieger B; Denizot C; Parmentier Y; Fardel O
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28375174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters.
    Sasabe H; Shimokawa Y; Shibata M; Hashizume K; Hamasako Y; Ohzone Y; Kashiyama E; Umehara K
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3497-508. PubMed ID: 27021329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian regulation of transporter expression and implications for drug disposition.
    Pácha J; Balounová K; Soták M
    Expert Opin Drug Metab Toxicol; 2021 Apr; 17(4):425-439. PubMed ID: 33353445
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction.
    Mao Q; Lai Y; Wang J
    Drug Metab Dispos; 2018 May; 46(5):561-566. PubMed ID: 29636376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Disposition of Imaging Biomarker Gadoxetate in Rats.
    Scotcher D; Melillo N; Tadimalla S; Darwich AS; Ziemian S; Ogungbenro K; Schütz G; Sourbron S; Galetin A
    Mol Pharm; 2021 Aug; 18(8):2997-3009. PubMed ID: 34283621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional ATP-binding cassette drug efflux transporters in isolated human and rat hepatocytes significantly affect assessment of drug disposition.
    Lundquist P; Englund G; Skogastierna C; Lööf J; Johansson J; Hoogstraate J; Afzelius L; Andersson TB
    Drug Metab Dispos; 2014 Mar; 42(3):448-58. PubMed ID: 24396144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards Improved Pharmacokinetic Models for the Analysis of Transporter-Mediated Hepatic Disposition of Drug Molecules with Positron Emission Tomography.
    Hernández Lozano I; Karch R; Bauer M; Blaickner M; Matsuda A; Wulkersdorfer B; Hacker M; Zeitlinger M; Langer O
    AAPS J; 2019 Apr; 21(4):61. PubMed ID: 31037511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of drug-transporter interactions using in vitro and in vivo models.
    Xia CQ; Milton MN; Gan LS
    Curr Drug Metab; 2007 May; 8(4):341-63. PubMed ID: 17504223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.